Aoti

Aoti Graham Number

The Graham Number of Aoti (AOTI.L) as of Nov 3, 2026 is 0.33 USD. In the previous year, Graham Number was 0.08 USD — a change of 321.40% (higher).

Graham Number

0.33USD

YoY

321.40%

Last updated:

Graham Number of Aoti is 2025 0.33 USD. Graham Number of Aoti was 2024 0.08 USD. It decreases by 321.40% higher compared to the previous year.

The Aoti Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2021
0.08 USD
Jan 1, 2025
0.33 USD
The Aoti Graham Number history
YEARGraham NumberYoY
0.33USD+321.40%
0.08USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aoti Stock analysis

What does Aoti do? Aoti Inc generates revenue through its wound care technology products, primarily TWO2 therapy and NEXA Negative Pressure Wound Therapy (NPWT). The company's TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch, designed for patient-administered treatment of chronic wounds. NEXA NPWT System is a disposable, multi-week solution for wound care, targeting healthcare providers who manage chronic wound cases. Aoti focuses on enhancing access to care and improving clinical outcomes for patients with chronic conditions, leveraging robust clinical evidence to support its products' safety and efficacy. Healthcare providers and institutions purchasing TWO2 and NEXA systems form the primary customer segment, driven by the need for clinically proven wound care solutions. The company's products are positioned to address chronic wound management globally, with emphasis on patient quality of life and health equity. Aoti's business model centers on delivering evidence-based therapies that improve patient outcomes while meeting healthcare systems' demands for effective, efficient care delivery. The company's revenue streams are derived from direct sales of TWO2 and NEXA systems to healthcare facilities and practitioners. Product offerings are structured to support both acute and chronic wound care needs, with TWO2 being a multi-modality patient-administered therapy and NEXA providing a flexible, disposable NPWT system. Aoti's focus on clinical evidence ensures its solutions align with healthcare providers' requirements for safety and efficacy in wound treatment. Aoti is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aoti stock

Graham Number of Aoti is 0.33 USD in 2025.

On Eulerpool you can find the complete historical development of Graham Number Aoti since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Aoti

All Key Metrics — Aoti